• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments on "Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis".

作者信息

Jayaraj Rama, Shaw Peter, Kumarasamy Chellan, Shetty Sameep S

机构信息

Department of Artificial Intelligence, Nanjing University of Information Science and Technology (NUIST), Nanjing, Jiangsu, China.

Northern Territory Institute of Research and Training, Darwin, Northern Territory, Australia.

出版信息

Int J Cancer. 2021 Jun 1;148(11):2857-2858. doi: 10.1002/ijc.33511. Epub 2021 Feb 19.

DOI:10.1002/ijc.33511
PMID:33567106
Abstract
摘要

相似文献

1
Comments on "Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis".对“细胞学正常但人乳头瘤病毒检测呈阳性的女性发生宫颈上皮内瘤变的累积风险：系统评价与荟萃分析”的评论
Int J Cancer. 2021 Jun 1;148(11):2857-2858. doi: 10.1002/ijc.33511. Epub 2021 Feb 19.
2
Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.回复：关于细胞学正常但人乳头瘤病毒检测呈阳性的女性发生宫颈上皮内瘤变累积风险的评论：系统评价与荟萃分析
Int J Cancer. 2021 Jun 1;148(11):2859-2860. doi: 10.1002/ijc.33510. Epub 2021 Feb 19.
3
Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.细胞学正常但 HPV 阳性女性的宫颈上皮内瘤变累积风险：系统评价和荟萃分析。
Int J Cancer. 2020 Nov 15;147(10):2695-2707. doi: 10.1002/ijc.33035. Epub 2020 May 26.
4
The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.年龄和高危型人乳头瘤病毒（hrHPV）状态对持续性 hrHPV 阳性、细胞学阴性筛查样本中高级别宫颈上皮内瘤变（CIN2+）患病率的影响：一项前瞻性队列研究。
BJOG. 2020 Sep;127(10):1260-1267. doi: 10.1111/1471-0528.16250. Epub 2020 May 3.
5
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益：通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
6
Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.意义不明确的非典型鳞状或腺细胞女性患者宫颈上皮内瘤变的检测：一项前瞻性研究。
Acta Obstet Gynecol Scand. 2003 Sep;82(9):883-9. doi: 10.1034/j.1600-0412.2003.00231.x.
7
Clinical characteristics of single human papillomavirus 53 infection: a retrospective study of 419 cases.单一型人乳头瘤病毒 53 感染的临床特征：419 例回顾性研究。
BMC Infect Dis. 2021 Nov 15;21(1):1158. doi: 10.1186/s12879-021-06853-7.
8
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.中国宫颈癌筛查中高危型人乳头瘤病毒检测的效果：一项多中心、开放标签、随机临床试验。
JAMA Oncol. 2021 Feb 1;7(2):263-270. doi: 10.1001/jamaoncol.2020.6575.
9
Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.HPV 持续感染女性在有组织筛查项目中退出后的阴道镜和组织病理学评估。
Am J Obstet Gynecol. 2020 Mar;222(3):253.e1-253.e8. doi: 10.1016/j.ajog.2019.09.039. Epub 2019 Oct 1.
10
The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.基于 8726 例病例的回顾性研究：L-SIL 细胞学检查女性中，扩展型高危型 HPV 基因分型在风险分层中的临床应用。
Cancer Cytopathol. 2022 Jul;130(7):542-550. doi: 10.1002/cncy.22573. Epub 2022 Mar 21.

引用本文的文献

1
A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.基于 miRNA 标志物的生存结局治疗诊断效果的临床研究：一项符合 PRISMA-P 指南的系统评价和综合荟萃分析方案。
Genes (Basel). 2022 Mar 5;13(3):463. doi: 10.3390/genes13030463.